Event dates
Webinar
Surgeons and Comprehensive Biomarker Testing for Lung Cancer Patients
What is the surgeon’s role in biomarker testing for lung cancer patients? In the November 4 episode of the STS Webinar Series, surgeons from different practice environments in the US and Canada offer perspectives about comprehensive biomarker testing, including for patients with inoperable or stage IV non-small cell lung cancer (NSCLC). They also explain how to implement a biomarker testing protocol and discuss targeted therapies for patients with resected epidermal growth factor receptor (EGFR)-positive adenocarcinoma.
This webinar is supported by AstraZeneca.
Moderators
 |
Farhood Farjah, MD, MPH University of Washington Seattle, WA |
 |
M. Blair Marshall, MD Brigham and Women’s Hospital Boston, MA |
Panelists
 |
Jessica S. Donington, MD, MSCR University of Chicago Chicago, IL |
 |
Janet P. Edwards, MD, MPH University of Calgary Calgary, AB |
 |
Biniam Kidane, MD, MSc University of Manitoba Winnipeg, MB |
 |
Svetlana Kotova, MD Oregon Health & Science University Portland, OR |
 |
Linda W. Martin, MD, MPH University of Virginia Charlottesville, VA |